Skip to content

Clinical trials

Terminated Phase 2 Mesothelioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Phase 2 Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20131
20141
20151
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Bayer1
Dana-Farber Cancer Institute1
Genzyme, a Sanofi Company1
Mayo Clinic1
University Health Network, Toronto1
University of Calgary1
Verastem, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma9
Esophageal Neoplasms2
Lung Neoplasms2
Mesothelioma, Malignant2
Adenoma1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Gastrointestinal Neoplasms1
Hypopharyngeal Neoplasms1
Laryngeal Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.